5th ILROG Continuing Education Conference - Radiotherapy in Modern Management of Lymphoma

Conference Date

May 25 - 26, 2024
Abstract Submission Deadline

May 2, 2024
Advanced Registration Deadline

May 23, 2024
On-Site Registration Date

May 24, 2024

Welcome Message

Dear Friends and Colleagues,

Course Director:

Joachim Yahalom, M.D.

Memorial Sloan Kettering Cancer Center

Course Co-Director:

Lena Specht, M.D.

Rigshospitalet, Copenhagen University Hospital

Local Organizer:

Yexiong Li, M.D. | Junlin Yi, M.D.

Cancer Hospital, Chinese Academy of Medical Sciences

Welcome to the 5th International Lymphoma Radiation Oncology Group (ILROG) Educational Conference: Radiotherapy in Modern Management of Lymphoma, to be held on the 25th & 26th of May, 2024, in Beijing, China. We are very pleased to extend you a warm invitation to the ILROG Beijing meeting.

The International Lymphoma Radiation Oncology Group (ILROG) is an international organization of academic leaders in the field of lymphoma. ILROG initiates, supports, and conducts research, develops and disseminates evidence-based guidelines for the field, dose, and technique of radiation therapy for all types of lymphomas, with the aim of advancing, coordinating, and optimizing the use of radiation therapy in lymphoma.

The 5th ILROG Continuing Education Conference, sponsored by the Department of Radiation Therapy, Cancer Hospital, Chinese Academy of Medical Sciences, invites internationally renowned lymphoma experts to focus on the application of high technology in lymphoma, lymphoma treatment in the age of immunity, optimized radiotherapy regimens, new drugs for lymphomas, immunotherapy, precision typing and diagnosis, and so on.

The two-day training will provide rich information and advancement in the fields in various formats, featuring expert keynote speeches, case discussions, and sharing of investigators' scientific findings.

The conference will cover a wide range of topics including Hodgkin's lymphoma, diffuse large B-cell lymphoma, inert lymphoma, extranodal lymphoma, plasma cell, myeloma and more.

We are committed to present you a unique and exciting educational opportunity for radiation oncologists, hematologists/medical oncologists, radiation therapists, physicists and nurses involving in the care of patients with hematological malignancies.

We look forward to welcoming you to Beijing in May 2024.

Invited Speaker